DMIIR
Drugs Made In America Acquisition II Corp. Right
NASDAQ · Financial Services · Asset Management · US
$0.08
+14.14%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
2.6%
Return on equity
2.5%
Return on assets
-0.3%
Return on invested capital
0.00x
Asset turnover
-$1.0M
Cash from operations
$0.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026